A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors. - Wikidata - awgldk - TriplyDB

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

http://www.wikidata.org/entity/Q43243195

about

PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites.Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids.Integrated 18F-fluorodeoxyglucose-positron emission tomography/dynamic contrast-enhanced computed tomography to phenotype non-small cell lung carcinoma Cushing's syndrome: epidemiology and developments in disease management.Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT Diagnostic Performance of (68)Ga-DOTATATE PET/CT, (18)F-FDG PET/CT and (131)I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma.Pulmonary mass in a 19-year-old male. Inflammatory myofibroblastic tumour Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung.Peptide-based imaging agents for cancer detection.PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India.Molecular imaging of neuroendocrine tumors The molecular pathogenesis and management of bronchial carcinoids.Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.Is 68Ga-DOTATATE the answer in lung carcinoid? : Case report and review of literature.18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis.PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature.Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.Management of bronchial carcinoids: international practice survey among the European Society of Thoracic Surgeons.Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?Long-term results of PRRT in advanced bronchopulmonary carcinoid.Non-functioning gastroenteropancreatic (GEP) tumors: a 111In-Pentetreotide SPECT/CT diagnostic study Dual Tracer PET Imaging (68Ga-DOTATATE and 18F-FDG) Features in Pulmonary Carcinoid: Correlation with Tumor Proliferation Index.Somatostatin receptor-based molecular imaging and therapy for neuroendocrine tumors.Neuroendocrine liver metastases: contributions of endoscopy and surgery to primary tumor search 18F-FDG PET/CT rarely provides additional information other than primary tumor detection in patients with pulmonary carcinoid tumors.Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors.Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

P2860

Q26992201-3527D871-A918-4C9C-AF27-95EDAD141B8B Q26996521-39052E67-9666-4A86-B7DB-4888E5351BE0 Q33588174-79C95067-6208-477B-9EC1-6E54EC5473C2 Q33767666-670A33FD-AC7A-4AC0-A1B6-D82A2CD0BC40 Q34385022-6B45C638-F217-40B6-9EB2-4D105AD294DD Q34410058-72A25DF8-DD10-4F25-BE0D-FADEF1F1A3A3 Q35531889-65701E9A-F321-4607-AF66-47F24076C523 Q35695753-3B959006-4A84-4069-A461-FC351B8B1AD0 Q35724965-07820D3E-7C44-456A-8C2C-522001EA87E1 Q35991166-DF2E14A0-14C3-45F8-9680-D86B72EA1A8C Q36149338-0E4B9B58-9C67-49D4-B850-3CF4F2A494F4 Q37427631-040006ED-F7AF-4336-A79B-97BA66DF274D Q37585965-641720E2-1530-4233-B5B5-17538FD9F267 Q37592451-AA96519E-F39E-4924-B832-5B5D180CE5D5 Q37730951-211768E2-00C9-410C-B190-F0158F00F4DC Q37833109-1621054E-6AC4-4241-9CB7-AFA9CC9AB415 Q37986605-2436EBB1-F76C-4A94-BB19-68E468D1205C Q38067704-492B74E9-F93A-4C03-8066-7CDB1969D7D2 Q38082417-5353F5C6-FEC2-4E29-B23A-06C2D63BA8BE Q38123057-06CE9AD6-6E3A-4DB1-AEEE-C2D6A8D1B269 Q38127505-B2106B90-61BF-49BF-9BC1-C8A02A2863AD Q38213643-A66DBBF9-9648-43A9-9EE8-13A11BD8CC70 Q38241845-8755676B-FAA5-438B-80A7-A82FA0301935 Q38469898-D978276E-F0FB-4CF6-9742-B9FD77ED2820 Q38557054-00F8DC35-73E1-4F1F-A885-68A60B54AF5B Q38853213-59065257-17B1-469C-A146-AD3941090E31 Q38898271-E8CFCCDC-44D1-4ABB-9F2E-4F47CC2E4EB7 Q40014600-A6382C0B-BD5B-4123-8254-7B665CC00E86 Q40516842-D3D1A5FD-4429-4941-9B4B-F89F669E3871 Q41180546-B2B8BC7A-FDF0-49AD-86AC-8ECF6B56E37C Q42320688-CF63D735-A5A9-457B-B356-9425AF870054 Q42548064-648CEF41-698C-4632-992A-0FF51826B4BE Q42592746-E56C2A00-F21D-4977-8244-DAE1079A0415 Q42882511-0BACD879-111A-4461-A062-CA18A1920348 Q43595918-8D7D89B0-A369-4CC9-81A2-43623DCC698F Q47135640-F0D9846E-ECF1-4E41-AA80-13A24A25C26C Q47378726-79964E8B-14D7-47C7-9E9E-0E94209734F1 Q47731752-75F0373B-4366-4731-BD7C-B4DADA041B97 Q47831315-2FB2AD16-A2AC-4D6F-B6EE-38EAF5D29703 Q48089118-FDCC04FD-E88D-4536-ACB8-491CD69D5F77

P2860

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

http://www.wikidata.org/entity/Q43243195

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@en

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@nl

type

label

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@en

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@nl

prefLabel

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@en

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@nl

P1433

Q43243195-F6BE8C23-820B-47F1-AAA7-1395B9AC98A3

P1476

Q43243195-D58DC9ED-C368-4676-94F7-E4770A922A26

P2093

Q43243195-25415853-AEBC-4E1F-AEA3-81A938D68D55

Q43243195-279C4F78-7684-484D-905E-30BEF4567759

Q43243195-2ED5BC35-A1F9-4461-BA99-972A78EB1E6C

Q43243195-7A08F433-469D-45EB-AF74-B381571D1861

Q43243195-806501F7-EA1D-4744-88F4-231FB14C516A

Q43243195-81F5603A-5962-4D21-8EEB-F3B300FB2966

Q43243195-A6BB8924-6F05-4D52-869E-B17810714055

P304

Q43243195-1C71CB7B-2939-4A0D-9F3A-65438C58E5AE

P31

Q43243195-4092E0B6-E0C5-4551-B45D-F89F9CD09819

P356

Q43243195-005ADF2F-A709-4526-81A8-0245C4CEF9EC

P407

Q43243195-93ABD040-5DBB-45DA-921B-0253FA5BBF04

P433

Q43243195-E2D66D91-FF61-4F2F-AD20-70B6EC55B278

P478

Q43243195-78EF7477-8D35-4271-958F-A0E13EE1A4D3

P577

Q43243195-6A06E1B4-23BF-4281-AFB3-DC70711D5FD1

P5875

Q43243195-03790F98-604A-471B-9B68-88198E0F9154

P698

Q43243195-A043C79B-7109-442F-9E72-D6E851E7C66F

P356

JNUMED.109.066639

P1433

The Journal of Nuclear Medicine

P1476

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors.

@en

P2093

Ashley M Groves

http://www.w3.org/2001/XMLSchema#string

Brendon G Conry

http://www.w3.org/2001/XMLSchema#string

Irfan Kayani

http://www.w3.org/2001/XMLSchema#string

Jamshed B Bomanji

http://www.w3.org/2001/XMLSchema#string

John Dickson

http://www.w3.org/2001/XMLSchema#string

Martyn Caplin

http://www.w3.org/2001/XMLSchema#string

Thida Win

http://www.w3.org/2001/XMLSchema#string

P304

1927-1932

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.109.066639

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38086544

http://www.w3.org/2001/XMLSchema#string

P698

19910422

http://www.w3.org/2001/XMLSchema#string